AMITRIPTYLINE AT LOW-DOSE AND TITRATED FOR IRRITABLE BOWEL SYNDROME AS SECOND-LINE TREATMENT (ATLANTIS): A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL IN PRIMARY CARE

Alexander Charles Ford  1     Alex Wright-Hughes  1     Sarah L. Alderson  1     Pei Loo Ow  1     Matthew J. Ridd  2     Robbie Foy  2     Felicity L. Bishop  3     Matthew Chaddock  4     Heather Cook  5     Deborah Cooper  5     Catherine Fernandez  5     Elspeth A. Guthrie  5     Suzanne Hartley  5     Amy Herbert  5     Daniel Howdon  5     Roberta Longo  5     Delia P. Muir  5     Taposhi Nath  6     Sonia Newman  6     Christopher M. Taylor  6     Emma J. Teasdale  6     Ruth Thornton  6     Amanda J. Farrin  6     Hazel A. Everitt  6    
1 University of Leeds, Leeds, United Kingdom
2 University of Bristol, Bristol, United Kingdom
3 University of Southampton, Southampton, United Kingdom
4 LetscureIBS, Leeds, United Kingdom
5 University of Exeter, Exeter, United Kingdom
6 Labcorp, Leeds, United Kingdom

Topic
IBD, Neurogastroenterology & Motility, Paediatrics, Small Intestine & Nutrition, Colorectal

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing